CardieX Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 34

Employees

  • Stock Symbol
  • CDX

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.09
  • (As of Tuesday Closing)

CardieX General Information

Description

CardieX Ltd is a health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia and Australia/New Zealand.

Contact Information

Website
www.cardiex.com
Formerly Known As
AtCor Medical
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 55 Lime Street, Barangaroo
  • Suite 301
  • Sydney, New South Wales 2000
  • Australia
+61 (02)
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • 55 Lime Street, Barangaroo
  • Suite 301
  • Sydney, New South Wales 2000
  • Australia
+61 (02)

CardieX Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardieX Stock Performance

As of 12-Nov-2024, CardieX’s stock price is $0.09. Its current market cap is $27.1M with 294M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.09 $0.07 $0.03 - $0.10 $27.1M 294M 343K

CardieX Financials Summary

As of 30-Sep-2024, CardieX has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2024 FY 2024 30-Jun-2024 FY 2023 30-Jun-2023 FY 2022 30-Jun-2022
EV 11,012 13,192 13,405 23,916
Revenue 7,147 3,095 2,947
EBITDA (3,687) (12,454) (8,548)
Net Income (4,434) (12,697) (8,558)
Total Assets 8,455 9,622 8,515
Total Debt 2,582 2,839 1,470
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CardieX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CardieX‘s full profile, request access.

Request a free trial

CardieX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
CardieX Ltd is a health technology company, developing solutions for health disorders. The AtCor Medical division develo
Diagnostic Equipment
Sydney, Australia
34 As of 2023

Melbourne, Australia
 

Leichhardt, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CardieX Competitors (3)

One of CardieX’s 3 competitors is Compumedics, a Corporation company based in Melbourne, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Compumedics Corporation Melbourne, Australia
Atomo Diagnostics Formerly VC-backed Leichhardt, Australia
Austco Healthcare Corporation Melbourne, Australia
You’re viewing 3 of 3 competitors. Get the full list »

CardieX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardieX Investments & Acquisitions (3)

CardieX’s most recent deal was a Merger/Acquisition with Blumio. The deal was made on 15-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Blumio 15-Nov-2022 Merger/Acquisition Monitoring Equipment
InHealth Lifestyle Therapeutics 30-Jun-2019 Seed Round Clinics/Outpatient Services
Blumio 01-Nov-2018 Early Stage VC Monitoring Equipment
To view CardieX’s complete investments and acquisitions history, request access »

CardieX Subsidiaries (1)

Company Name Industry Location Founded
InHealth Lifestyle Therapeutics Clinics/Outpatient Services Los Angeles, CA
To view CardieX’s complete subsidiaries history, request access »

CardieX FAQs

  • When was CardieX founded?

    CardieX was founded in 2005.

  • Where is CardieX headquartered?

    CardieX is headquartered in Sydney, Australia.

  • What is the size of CardieX?

    CardieX has 34 total employees.

  • What industry is CardieX in?

    CardieX’s primary industry is Diagnostic Equipment.

  • Is CardieX a private or public company?

    CardieX is a Public company.

  • What is CardieX’s stock symbol?

    The ticker symbol for CardieX is CDX.

  • What is the current stock price of CardieX?

    As of 12-Nov-2024 the stock price of CardieX is $0.09.

  • What is the current market cap of CardieX?

    The current market capitalization of CardieX is $27.1M.

  • Who are CardieX’s competitors?

    Compumedics, Atomo Diagnostics, and Austco Healthcare are competitors of CardieX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »